GMT Capital’s BeOne Medicines Ltd ONC Stock Holding History

GMT Capital’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,622	Closed	-$1.94M	–	79
2024 Q2	$1.94M	Buy	+13,622	New	+$2.1M	0.07%	47

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

GMT Capital's ONC Position: Q3 2024 in Review

GMT Capital sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 13,622 shares — an estimated $1.94M sold.

GMT Capital first reported a position in ONC in Q2 2024 and held it in 1 quarter. The position peaked at $1.94M in Q2 2024. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

GMT Capital reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
GMT Capital sold 13,622 BeOne Medicines Ltd shares in Q3 2024, an estimated $1.94M.
GMT Capital first reported a position in BeOne Medicines Ltd in Q2 2024 and held it in 1 quarter.
GMT Capital's BeOne Medicines Ltd position peaked at $1.94M in Q2 2024.
228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on GMT Capital's 13F filing for Q3 2024, filed 14 Nov 2024.